ID
27264
Description
Study ID: 101468/188 Clinical Study ID: SKF-101468/188 Study Title:A Study of the Maintained Efficacy and Safety of Ropinirole Versus Placebo in the Long Term Treatment of Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Parkinson Disease Module: Medical Procedures
Keywords
Versions (1)
- 11/6/17 11/6/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 6, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/188
Similar models
Medical Procedures
- StudyEvent: ODM
C0008976 (UMLS CUI-2)
C0035258 (UMLS CUI-3)
C0332307 (UMLS CUI [1,2])
C0199171 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])